| Literature DB >> 14570350 |
Sarah Richards1, Jay N Umbreit, Michael P Fanucchi, Joan Giblin, Fadlo Khuri.
Abstract
A 74-year-old man was admitted with rhabdomyolysis after undergoing initial treatment for gastrointestinal cancer with irinotecan. The syndrome partially resolved after the discontinuation of all of his usual medications, including his chronic selective serotonin reuptake inhibitor (SSRI). The rhabdomyolysis was exacerbated upon reinitiation of the SSRI and disappeared when the SSRI was discontinued. The combination of irinotecan and SSRI resulted in potentially lethal rhabdomyolysis.Entities:
Mesh：
Substances：
Year: 2003 PMID： 14570350 DOI： 10.1097/01.SMJ.0000084311.35864.D6
Source DB: PubMed Journal: South Med J ISSN： 0038-4348 Impact factor: 0.954